These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 36858520)
21. Pathogenesis of Guillain-Barré syndrome. Hughes RA; Hadden RD; Gregson NA; Smith KJ J Neuroimmunol; 1999 Dec; 100(1-2):74-97. PubMed ID: 10695718 [TBL] [Abstract][Full Text] [Related]
22. A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome. Louwen R; Horst-Kreft D; de Boer AG; van der Graaf L; de Knegt G; Hamersma M; Heikema AP; Timms AR; Jacobs BC; Wagenaar JA; Endtz HP; van der Oost J; Wells JM; Nieuwenhuis EE; van Vliet AH; Willemsen PT; van Baarlen P; van Belkum A Eur J Clin Microbiol Infect Dis; 2013 Feb; 32(2):207-26. PubMed ID: 22945471 [TBL] [Abstract][Full Text] [Related]
23. Campylobacter jejuni O:19 serotype-associated Guillain-Barré syndrome in a child: the first case reported from Greece. Chatzipanagiotou S; Kilidireas K; Trimis G; Nicolaou C; Anagnostouli M; Athanassaki C; Giannoulia A; Legakis N; Youroukos S Clin Microbiol Infect; 2003 Jan; 9(1):69-72. PubMed ID: 12691547 [TBL] [Abstract][Full Text] [Related]
24. Guillain-Barré syndrome associated with Campylobacter jejuni infection in England, 2000-2001. Tam CC; Rodrigues LC; O'Brien SJ Clin Infect Dis; 2003 Jul; 37(2):307-10. PubMed ID: 12856224 [TBL] [Abstract][Full Text] [Related]
26. Emergence and Molecular Epidemiology of Campylobacter jejuni ST-2993 Associated with a Large Outbreak of Guillain-Barré Syndrome in Peru. Quino W; Caro-Castro J; Mestanza O; Hurtado V; Zamudio ML; Cruz-Gonzales G; Gavilan RG Microbiol Spectr; 2022 Oct; 10(5):e0118722. PubMed ID: 35972275 [TBL] [Abstract][Full Text] [Related]
27. Anti-ganglioside antibodies and clinical outcome of patients with Guillain-Barré Syndrome in northeast Brazil. Dourado ME; Duarte RC; Ferreira LC; Queiroz JW; Illa I; Perez-Perez G; Guerrant RL; Jerônimo SM Acta Neurol Scand; 2003 Aug; 108(2):102-8. PubMed ID: 12859286 [TBL] [Abstract][Full Text] [Related]
28. Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies. Ang CW; Yuki N; Jacobs BC; Koga M; Van Doorn PA; Schmitz PI; Van Der Meché FG Neurology; 1999 Dec; 53(9):2122-7. PubMed ID: 10599792 [TBL] [Abstract][Full Text] [Related]
29. Guillain-Barré Syndrome Outbreak in Peru 2019 Associated With Ramos AP; Leonhard SE; Halstead SK; Cuba MA; Castañeda CC; Dioses JA; Tipismana MA; Abanto JT; Llanos A; Gourlay D; Grogl M; Ramos M; Rojas JD; Meza R; Puiu D; Sherman RM; Salzberg SL; Simner PJ; Willison HJ; Jacobs BC; Cornblath DR; Umeres HF; Pardo CA Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33547152 [TBL] [Abstract][Full Text] [Related]
30. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection. Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754 [TBL] [Abstract][Full Text] [Related]
31. Incidence of Guillain-Barré syndrome following infection with Campylobacter jejuni. McCarthy N; Giesecke J Am J Epidemiol; 2001 Mar; 153(6):610-4. PubMed ID: 11257070 [TBL] [Abstract][Full Text] [Related]
32. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome]. Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750 [TBL] [Abstract][Full Text] [Related]
33. Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barré syndrome onset subsequent to Campylobacter jejuni enteritis. Odaka M; Koga M; Yuki N; Susuki K; Hirata K J Neurol Sci; 2003 Jun; 210(1-2):99-103. PubMed ID: 12736097 [TBL] [Abstract][Full Text] [Related]
34. Th1/Th17-mediated Immunity and Protection from Peripheral Neuropathy in Wildtype and IL10 Brudvig JM; Cluett MM; Gensterblum-Miller EU; Chen J; Bell JA; Mansfield LS Comp Med; 2022 Apr; 72(2):63-77. PubMed ID: 35272743 [No Abstract] [Full Text] [Related]
35. Campylobacter infection as a trigger for Guillain-Barré syndrome in Egypt. Wierzba TF; Abdel-Messih IA; Gharib B; Baqar S; Hendaui A; Khalil I; Omar TA; Khayat HE; Putnam SD; Sanders JW; Ng LK; Price LJ; Scott DA; Frenck RR PLoS One; 2008; 3(11):e3674. PubMed ID: 19002255 [TBL] [Abstract][Full Text] [Related]
36. Campylobacter jejuni infection as a cause of the Guillain-Barré syndrome. Allos BM Infect Dis Clin North Am; 1998 Mar; 12(1):173-84. PubMed ID: 9494837 [TBL] [Abstract][Full Text] [Related]